Pfizer Consumer Healthcare Deal History & Licensing Activity
Pfizer Consumer Healthcare is a life sciences. Over the past three years, Pfizer Consumer Healthcare has been involved in 8 licensing and acquisition transactions, with a primary focus on Bispecific Antibodies (5 deals).
Deals (12mo)
2
Active Trials
0
Top Modality
Bispecific Antibodies
Focus Area
Option Deals
Pfizer Consumer Healthcare Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Pfizer Consumer Healthcare in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| bispecific immuno-oncology assets | Pfizer | Bispecific Antibodies | Unknown | option | Jul 18, 2026 |
| SSGJ-707 (PD-1/VEGF bispecific) | Pfizer | Bispecific Antibodies | Unknown | license | Jul 12, 2026 |
Pfizer Consumer Healthcare Pipeline Focus
Therapeutic areas and modalities where Pfizer Consumer Healthcare is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Pfizer Consumer Healthcare Strategic Signals
Key indicators of Pfizer Consumer Healthcare's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
See How Your Asset Matches Pfizer Consumer Healthcare's Portfolio
Use Solidus to benchmark upfront payments, milestones, and royalties for Option Deals assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Bispecific Antibodies Benchmarks
Upfront, milestone, and royalty benchmarks for bispecific antibodies deals
Antibodies Benchmarks
Upfront, milestone, and royalty benchmarks for antibodies deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Pfizer Consumer Healthcare Licensing & Deal Activity
Pfizer Consumer Healthcare is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 8 deals over the past three years, Pfizer Consumer Healthcare ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Pfizer Consumer Healthcare include Option Deals (5 deals and trials), and Codev Deals (5 deals and trials). In terms of modality, Pfizer Consumer Healthcare has shown particular interest in bispecific antibodies, antibodies, other.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Pfizer Consumer Healthcare and 850+ other biopharma companies. Use our Solidus to benchmark your asset against Pfizer Consumer Healthcare's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.